241 related articles for article (PubMed ID: 21073603)
1. Strategy for eliminating gastric cancer in Japan.
Asaka M; Kato M; Graham DY
Helicobacter; 2010 Dec; 15(6):486-90. PubMed ID: 21073603
[TBL] [Abstract][Full Text] [Related]
2. [Strategies for extermination of gastric cancer from Japan].
Asaka M
Nihon Rinsho; 2011 Jan; 69(1):173-82. PubMed ID: 21226280
[TBL] [Abstract][Full Text] [Related]
3. [Elimination of gastric cancer from Japan].
Asaka M
Nihon Rinsho; 2012 Oct; 70(10):1667-72. PubMed ID: 23198543
[TBL] [Abstract][Full Text] [Related]
4. [Cost cut of cancer by a shift in gastric cancer risk screening (serum ABC classification) combined with eradication of H. pylori, and H. pylori test and treatment program in young people].
Ohwada S; Inui Y; Inui M; Yoshikawa M; Sohara N
Nihon Rinsho; 2012 Oct; 70(10):1731-7. PubMed ID: 23198553
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Helicobacter pylori screening followed by eradication treatment for employees in Japan.
Kowada A
Epidemiol Infect; 2018 Oct; 146(14):1834-1840. PubMed ID: 30056808
[TBL] [Abstract][Full Text] [Related]
6. High-Negative Anti-
Inoue M; Sawada N; Goto A; Shimazu T; Yamaji T; Iwasaki M; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):420-426. PubMed ID: 31826914
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
8. Economic and health impacts of introducing Helicobacter pylori eradication strategy into national gastric cancer policy in Japan: A cost-effectiveness analysis.
Kowada A; Asaka M
Helicobacter; 2021 Oct; 26(5):e12837. PubMed ID: 34278663
[TBL] [Abstract][Full Text] [Related]
9. Metachronous gastric cancer after successful Helicobacter pylori eradication.
Shiotani A; Haruma K; Graham DY
World J Gastroenterol; 2014 Sep; 20(33):11552-9. PubMed ID: 25206262
[TBL] [Abstract][Full Text] [Related]
10. Recent development of gastric cancer prevention.
Kato M; Asaka M
Jpn J Clin Oncol; 2012 Nov; 42(11):987-94. PubMed ID: 23018579
[TBL] [Abstract][Full Text] [Related]
11. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.
Graham DY; Asaka M
J Gastroenterol; 2010; 45(1):1-8. PubMed ID: 19714291
[TBL] [Abstract][Full Text] [Related]
12. Gastric Cancer Screening by Combined Determination of Serum
Chen XZ; Huang CZ; Hu WX; Liu Y; Yao XQ
Chin Med J (Engl); 2018 May; 131(10):1232-1239. PubMed ID: 29722342
[TBL] [Abstract][Full Text] [Related]
13. Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan.
Asaka M; Kato M; Sakamoto N
J Gastroenterol; 2014 Jan; 49(1):1-8. PubMed ID: 24162382
[TBL] [Abstract][Full Text] [Related]
14. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer.
Aromaa A; Kosunen TU; Knekt P; Maatela J; Teppo L; Heinonen OP; Härkönen M; Hakama MK
Am J Epidemiol; 1996 Jul; 144(2):142-9. PubMed ID: 8678045
[TBL] [Abstract][Full Text] [Related]
15. Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.
Yanaoka K; Oka M; Yoshimura N; Mukoubayashi C; Enomoto S; Iguchi M; Magari H; Utsunomiya H; Tamai H; Arii K; Yamamichi N; Fujishiro M; Takeshita T; Mohara O; Ichinose M
Int J Cancer; 2008 Aug; 123(4):917-26. PubMed ID: 18508314
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori and the development of atrophic gastritis].
Takahashi S; Igarashi H; Masubuchi N; Ishiyama N; Saito S; Aoyagi T; Itoh T; Hirata I
Nihon Rinsho; 1993 Dec; 51(12):3231-5. PubMed ID: 8283639
[TBL] [Abstract][Full Text] [Related]
17. Effect on Helicobacter pylori eradication therapy against gastric cancer in Japan.
Tsuda M; Asaka M; Kato M; Matsushima R; Fujimori K; Akino K; Kikuchi S; Lin Y; Sakamoto N
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28771894
[TBL] [Abstract][Full Text] [Related]
18. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
[TBL] [Abstract][Full Text] [Related]
19. No association between AICDA 7888 C/T polymorphism, Helicobacter pylori seropositivity, and the risk of atrophic gastritis and gastric cancer in Japanese.
Hishida A; Matsuo K; Goto Y; Mitsuda Y; Hiraki A; Naito M; Wakai K; Tajima K; Hamajima N
Gastric Cancer; 2010 Mar; 13(1):43-9. PubMed ID: 20373075
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of
Kowada A
Scand J Gastroenterol; 2019 Jun; 54(6):685-689. PubMed ID: 31190581
[No Abstract] [Full Text] [Related]
[Next] [New Search]